Literature DB >> 22880479

[Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)].

Katarzyna Jankiewicz1, Beata Kulik-Rechberger, Łukasz Nowakowski, Tomasz Rechberger.   

Abstract

Nerve growth factor is a complex regulator of neural plasticity along the micturition pathways. The aim of this review is to summarize the current evidence for a role of NGF in urinary bladder function both in experimental and clinical settings. There is bulk of strong evidence that experimental administration of NGF elicits the symptoms of increased sensation, urgency and bladder hyperreflexia which strongly resemble overactive bladder syndrome (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS). Therefore in human studies there are attempts to employ urinary NGF levels as a diagnostic marker in various forms of OAB and IC/PBS. It has been shown that urinary NGF levels are correlated with severity of OAB symptoms and in patients successfully treated with antimuscarinics agents or detrusor botulinum toxin injection, urinary NGF levels decrease significantly in association with reduction of urgency severity

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22880479

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  1 in total

1.  Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse.

Authors:  Katarzyna Jankiewicz; Michał Bogusiewicz; Łukasz Nowakowski; Tomasz Rechberger; Artur Rogowski; Pawel Miotla
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.